Author： Hack Sabine Nash Lawrence T
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.5, 2002-05, pp. : 555-571
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Treatment of Anxiety Disorders in Children and Adolescents
Child and Adolescent Psychopharmacology News, Vol. 19, Iss. 5, 2014-10 ,pp. :
Access to resources
Recommend
Pharmacological treatment of anxiety disorders: an overview
By Leacute pine J.P. Pelissolo A.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Pharmacological Treatment of Depression in Children and Adolescents
Pediatric Drugs, Vol. 1, Iss. 3, 1999-07 ,pp. :
Room for Improvement in the Pharmacological Treatment of Anxiety Disorders
Current Pharmaceutical Design, Vol. 14, Iss. 33, 2008-11 ,pp. :
Spotlight on Fluvoxamine in Anxiety Disorders in Children and Adolescents
CNS Drugs, Vol. 16, Iss. 2, 2002-01 ,pp. :